| abstract |
The present invention partially provides a compound of formula I and a pharmaceutically acceptable salt thereof; its preparation method; an intermediate for its preparation; and a composition containing such a compound or salt; and its use in the treatment of MAGL-mediated diseases and Use for disorders including, for example, pain, inflammatory disorders, traumatic brain injury, depression, anxiety, Alzheimer's disease, metabolic disorders, stroke, or cancer. |